FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982482955> ?p ?o ?g. }

• W1982482955 endingPage "1807" @default.
• W1982482955 startingPage "1797" @default.
• W1982482955 abstract "Endocannabinoids exert numerous effects in the CNS under physiological and pathological conditions. The aim of the present study was to examine whether the endocannabinoid N-arachidonoyldopamine (NADA) may protect neurons in excitotoxically lesioned organotypic hippocampal slice cultures (OHSC). OHSC were excitotoxically lesioned by application of N–methyl-d-aspartate (NMDA, 50 μM) for 4 h and subsequently treated with different NADA concentrations (0.1 pM–50 μM) alone or in combination with cannabinoid receptor antagonists. NADA protected dentate gyrus granule cells and caused a slight reduction in the number of microglial cells. The number of degenerated neurons significantly decreased between 100 pM and 10 μM NADA (p < 0.05). To identify the responsive receptor type of NADA mediated neuroprotection, we applied the cannabinoid (CB) receptor 1 (CB1) inverse agonist/antagonist AM251, CB2 inverse agonist/antagonist AM630, abnormal-cannabidiol (abn-CBD)-sensitive receptor antagonist O-1918, transient receptor potential channel V1 (TRPV1) antagonist 6-iodonordihydrocapsaicin and A1 (TRPA1) antagonist HC-030031. Neuroprotective properties of low (1 nM) but not high (10 μM) NADA concentrations were solely blocked by AM251 and were absent in CB1−/− mice. AM630, O-1918, 6-iodonordihydrocapsaicin and HC-030031 showed no effects at all NADA concentrations applied. Our findings demonstrate that NADA protects dentate gyrus granule cells by acting via CB1. NADA reduced the number of microglial cells at distinct concentrations. TRPV1 and TRPA1 were not involved in NADA mediated neuroprotection. Thus, our data implicate that NADA mediated activation of neuronal CB1 may serve as a novel pharmacological target to mitigate symptoms of neuronal damage." @default.
• W1982482955 created "2016-06-24" @default.
• W1982482955 creator A5010289715 @default.
• W1982482955 creator A5023263973 @default.
• W1982482955 creator A5030838197 @default.
• W1982482955 creator A5041213950 @default.
• W1982482955 creator A5047693863 @default.
• W1982482955 creator A5052497026 @default.
• W1982482955 creator A5064139088 @default.
• W1982482955 creator A5075924009 @default.
• W1982482955 creator A5085502166 @default.
• W1982482955 creator A5087977424 @default.
• W1982482955 date "2012-03-01" @default.
• W1982482955 modified "2023-10-04" @default.
• W1982482955 title "The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1)" @default.
• W1982482955 cites W1494186970 @default.
• W1982482955 cites W1511198581 @default.
• W1982482955 cites W1552900953 @default.
• W1982482955 cites W1592286181 @default.
• W1982482955 cites W1654566502 @default.
• W1982482955 cites W1968740815 @default.
• W1982482955 cites W1973645562 @default.
• W1982482955 cites W1976127510 @default.
• W1982482955 cites W1982069349 @default.
• W1982482955 cites W1982291289 @default.
• W1982482955 cites W1984928802 @default.
• W1982482955 cites W1989155012 @default.
• W1982482955 cites W1990903837 @default.
• W1982482955 cites W1996615067 @default.
• W1982482955 cites W2006376420 @default.
• W1982482955 cites W2010086382 @default.
• W1982482955 cites W2011361113 @default.
• W1982482955 cites W2016821576 @default.
• W1982482955 cites W2018003279 @default.
• W1982482955 cites W2018810438 @default.
• W1982482955 cites W2020587065 @default.
• W1982482955 cites W2024356032 @default.
• W1982482955 cites W2030017828 @default.
• W1982482955 cites W2030237971 @default.
• W1982482955 cites W2032307129 @default.
• W1982482955 cites W2032715817 @default.
• W1982482955 cites W2034679108 @default.
• W1982482955 cites W2035898155 @default.
• W1982482955 cites W2041728393 @default.
• W1982482955 cites W2044296969 @default.
• W1982482955 cites W2046136399 @default.
• W1982482955 cites W2050417486 @default.
• W1982482955 cites W2053251168 @default.
• W1982482955 cites W2054104195 @default.
• W1982482955 cites W2055696035 @default.
• W1982482955 cites W2056188558 @default.
• W1982482955 cites W2060589571 @default.
• W1982482955 cites W2064128689 @default.
• W1982482955 cites W2064230118 @default.
• W1982482955 cites W2064441047 @default.
• W1982482955 cites W2064549941 @default.
• W1982482955 cites W2071222789 @default.
• W1982482955 cites W2073814752 @default.
• W1982482955 cites W2076324460 @default.
• W1982482955 cites W2085802434 @default.
• W1982482955 cites W2085989406 @default.
• W1982482955 cites W2092535327 @default.
• W1982482955 cites W2094553781 @default.
• W1982482955 cites W2095254913 @default.
• W1982482955 cites W2099414466 @default.
• W1982482955 cites W2109645143 @default.
• W1982482955 cites W2111152176 @default.
• W1982482955 cites W2112755850 @default.
• W1982482955 cites W2112924959 @default.
• W1982482955 cites W2118590048 @default.
• W1982482955 cites W2125686120 @default.
• W1982482955 cites W2128024488 @default.
• W1982482955 cites W2133702956 @default.
• W1982482955 cites W2142460361 @default.
• W1982482955 cites W2146141725 @default.
• W1982482955 cites W2150280637 @default.
• W1982482955 cites W2150675101 @default.
• W1982482955 cites W2913636289 @default.
• W1982482955 cites W4254239496 @default.
• W1982482955 cites W4294216491 @default.
• W1982482955 doi "https://doi.org/10.1016/j.neuropharm.2011.11.023" @default.
• W1982482955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22186081" @default.
• W1982482955 hasPublicationYear "2012" @default.
• W1982482955 type Work @default.
• W1982482955 sameAs 1982482955 @default.
• W1982482955 citedByCount "21" @default.
• W1982482955 countsByYear W19824829552014 @default.
• W1982482955 countsByYear W19824829552016 @default.
• W1982482955 countsByYear W19824829552017 @default.
• W1982482955 countsByYear W19824829552019 @default.
• W1982482955 countsByYear W19824829552021 @default.
• W1982482955 countsByYear W19824829552022 @default.
• W1982482955 crossrefType "journal-article" @default.
• W1982482955 hasAuthorship W1982482955A5010289715 @default.
• W1982482955 hasAuthorship W1982482955A5023263973 @default.
• W1982482955 hasAuthorship W1982482955A5030838197 @default.
• W1982482955 hasAuthorship W1982482955A5041213950 @default.
• W1982482955 hasAuthorship W1982482955A5047693863 @default.

• next